NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • HK • USD
Regencell Bioscience Holdings Limited (RGC) has a consensus analyst rating of Hold, based on 4 analysts covering the stock. Of those, 0 recommend buying, 4 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
